Company Filing History:
Years Active: 1993-2006
Title: Brent K Blackburn: Innovator in Pharmaceutical Chemistry
Introduction
Brent K Blackburn is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on developing innovative prodrugs and inhibitors that have the potential to improve therapeutic outcomes.
Latest Patents
One of his latest patents is for Halo-alkoxycarbonyl prodrugs. These derivatives serve as prodrug moieties for pharmaceutical agents that contain a basic or polar nitrogen functionality. The prodrugs are formulated as pharmaceutical compositions and are utilized in various methods of treatment. Another significant patent is for tricyclic inhibitors of the vitronectin receptor. This tricyclic benzodiazepine derivative acts as a nonpeptidyl platelet aggregation inhibitor. It effectively inhibits fibrinogen binding to the GPIIb IIIa receptor and is included in therapeutic compositions for treating diseases where blocking platelet aggregation is necessary. These nonpeptidyl inhibitors are often combined with thrombolytics and anticoagulants to enhance their efficacy.
Career Highlights
Brent has worked with prominent organizations such as Genentech, Inc. and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Kirk D Robarge and Todd C Somers. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Brent K Blackburn's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic agents that can improve patient care.